<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37946190</PMID><DateCompleted><Year>2023</Year><Month>11</Month><Day>13</Day></DateCompleted><DateRevised><Year>2023</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2662-7671</ISSN><JournalIssue CitedMedium="Internet"><Volume>23</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>09</Day></PubDate></JournalIssue><Title>BMC complementary medicine and therapies</Title><ISOAbbreviation>BMC Complement Med Ther</ISOAbbreviation></Journal><ArticleTitle>Effectiveness of an amygdala and insula retraining program combined with mindfulness training to improve the quality of life in patients with long COVID: a randomized controlled trial protocol.</ArticleTitle><Pagination><StartPage>403</StartPage><MedlinePgn>403</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">403</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12906-023-04240-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There has been growing clinical awareness in recent years of the long-term physical and psychological consequences of the SARS-CoV-2 virus, known as Long COVID. The prevalence of Long COVID is approximately 10% of those infected by the virus. Long COVID is associated with physical and neuropsychological symptoms, including those related to mental health, psychological wellbeing, and cognition. However, research on psychological interventions is still in its early stages, in which means that available results are still limited. The main objective of this study is to evaluate the effects of a program based on amygdala and insula retraining (AIR) combined with mindfulness training (AIR&#x2009;+&#x2009;Mindfulness) on the improvement of quality of life, psychological well-being, and cognition in patients with Long COVID.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This study protocol presents a single-blind randomized controlled trial (RCT) that encompasses baseline, post-treatment, and six-month follow-up assessment time points. A total of 100 patients diagnosed with Long COVID by the Spanish National Health Service will be randomly assigned to either AIR&#x2009;+&#x2009;Mindfulness (n&#x2009;=&#x2009;50) or relaxation intervention (n&#x2009;=&#x2009;50), the latter as a control group. The primary outcome will be quality of life assessed using the Short Form-36 Health Survey (SF-36). Additional outcomes such as fatigue, pain, anxiety, memory, and sleep quality will also be evaluated. Mixed effects regression models will be used to estimate the effectiveness of the program, and effect size calculations will be made.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">Long COVID syndrome is a clinical condition characterized by the persistence of symptoms for at least 12 weeks after the onset of COVID-19 that significantly affects people's quality of life. This will be the first RCT conducted in Spain to apply a psychotherapy program for the management of symptoms derived from Long COVID. Positive results from this RCT may have a significant impact on the clinical context by confirming the beneficial effect of the intervention program being evaluated on improving the symptoms of Long COVID syndrome and aiding the development of better action strategies for these patients.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">Clinical Trials.gov NCT05956405. Registered on July 20, 2023.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gasi&#xf3;n</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcel&#xf3;-Soler</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain. a.barcelo@unizar.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Network on Chronicity, Primary Care and Health Promotion, RICAPPS, Zaragoza, RD21/0016/0005, Spain. a.barcelo@unizar.es.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>University of Zaragoza, Huesca, Spain. a.barcelo@unizar.es.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltr&#xe1;n-Ruiz</LastName><ForeName>Mar&#xed;a</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Network on Chronicity, Primary Care and Health Promotion, RICAPPS, Zaragoza, RD21/0016/0005, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hijar-Aguinaga</LastName><ForeName>Rinchen</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Camarero-Grados</LastName><ForeName>Loreto</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Del-Hoyo</LastName><ForeName>Yolanda</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Network on Chronicity, Primary Care and Health Promotion, RICAPPS, Zaragoza, RD21/0016/0005, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xed;a-Campayo</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Aragon Institute for Health Research, IIS Aragon, Zaragoza, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Network on Chronicity, Primary Care and Health Promotion, RICAPPS, Zaragoza, RD21/0016/0005, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Montero-Marin</LastName><ForeName>Jesus</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Psychiatry, University of Oxford, Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Teaching, Research &amp; Innovation Unit, Parc Sanitari Sant Joan de D&#xe9;u, Sant Boi de Llobregat, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Consortium for Biomedical Research in Epidemiology &amp; Public Health (CIBER Epidemiology and Public Health - CIBERESP), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT05956405</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D000078325">Clinical Trial Protocol</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>11</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Complement Med Ther</MedlineTA><NlmUniqueID>101761232</NlmUniqueID><ISSNLinking>2662-7671</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064866" MajorTopicYN="Y">Mindfulness</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016032" MajorTopicYN="N">Randomized Controlled Trials as Topic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Amygdala Insula Retraining</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Mindfulness training</Keyword><Keyword MajorTopicYN="N">Psychological interventions</Keyword><Keyword MajorTopicYN="N">Quality of life</Keyword><Keyword MajorTopicYN="N">Randomized Controlled Trial</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>10</Day><Hour>0</Hour><Minute>4</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37946190</ArticleId><ArticleId IdType="pmc">PMC10634181</ArticleId><ArticleId IdType="doi">10.1186/s12906-023-04240-0</ArticleId><ArticleId IdType="pii">10.1186/s12906-023-04240-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ortona E, Malorni W, Long COVID. To investigate immunological mechanisms and sex/gender related aspects as fundamental steps for a tailored therapy. Eur Respir J. 2022;59(2). 10.1183/13993003.02245-2021</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8462012</ArticleId><ArticleId IdType="pubmed">34531277</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong CMM, Le YNJ, Boon GJAM, Barco S, Klok FA, Siegerink B. Eight lessons from 2 years of use of the Post-COVID-19 functional status scale. Eur Respir J. 2023;61(5):10&#x2013;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10151454</ArticleId><ArticleId IdType="pubmed">37080570</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ. Long COVID and myalgic encephalomyelitis/chronic Fatigue Syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Med. 2021;57(5).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Guidelines NICE. COVID-19 rapid guideline: managing the long-term effects of COVID-19. NICE Guidel. 2020;(18 December 2020):1&#x2013;35. Available from: https://www.nice.org.uk/terms-and</Citation></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crooks MG, Post. -COVID-19 Symptom Burden: What is Long-COVID and How Should We Manage It? Lung. 2021;199(2):113&#x2013;9. 10.1007/s00408-021-00423-z</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V, Nasi M, Bianco F, Seferovic J, Ivkovic V, Gallina S et al. Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: Gender makes a difference. Trends Cardiovasc Med. 2022;32(1):12&#x2013;7. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1050173821001158</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490128</ArticleId><ArticleId IdType="pubmed">34619336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bautista-Rodriguez E, Cort&#xe9;s-&#xc1;lvarez NY, Vuelvas-Olmos CR, Reyes-Meza V, Gonz&#xe1;lez-L&#xf3;pez T, Flores-delos&#xc1;ngeles C, et al. Stress, anxiety, depression and long COVID symptoms. Fatigue Biomed Heal Behav. 2023;11(1):35&#x2013;54. doi: 10.1080/21641846.2022.2154500.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2022.2154500</ArticleId></ArticleIdList></Reference><Reference><Citation>Fancourt D, Steptoe A, Bu F. Psychological consequences of long COVID: comparing trajectories of depressive and anxiety symptoms before and after contracting SARS-CoV-2 between matched long- and short-COVID groups. Br J Psychiatry. 2023;222(2):74&#x2013;81. doi: 10.1192/bjp.2022.155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.2022.155</ArticleId><ArticleId IdType="pmc">PMC7614126</ArticleId><ArticleId IdType="pubmed">36458509</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-las-Pe&#xf1;as C, Florencio LL, G&#xf3;mez-Mayordomo V, Cuadrado ML, Palacios-Ce&#xf1;a D, Raveendran AV. Proposed integrative model for post-COVID symptoms. Diabetes Metab Syndr Clin Res Rev. 2021;15(4):18&#x2013;9. doi: 10.1016/j.dsx.2021.05.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.05.032</ArticleId><ArticleId IdType="pmc">PMC8168334</ArticleId><ArticleId IdType="pubmed">34186367</ArticleId></ArticleIdList></Reference><Reference><Citation>Han JH, Womack KN, Tenforde MW, Files DC, Gibbs KW, Shapiro NI, et al. Associations between persistent symptoms after mild COVID-19 and long-term health status, quality of life, and psychological distress. Influenza Other Respi Viruses. 2022;16(4):680&#x2013;9. doi: 10.1111/irv.12980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/irv.12980</ArticleId><ArticleId IdType="pmc">PMC9111447</ArticleId><ArticleId IdType="pubmed">35347854</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A, Thomas N, Ellul MA, Davies NWS, Pollak TA, Tenorio EL et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry. 2020;7(10):875&#x2013;82. Available from: https://linkinghub.elsevier.com/retrieve/pii/S221503662030287X</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Scordo KA, Richmond MM, Munro N. Post&#x2013;COVID-19 Syndrome: Theoretical Basis, Identification, and Management. AACN Adv Crit Care. 2021;32(2):188&#x2013;94. Available from: https://aacnjournals.org/aacnacconline/article/32/2/188/31445/Post-COVID-19-Syndrome-Theoretical-Basis</Citation><ArticleIdList><ArticleId IdType="pubmed">33942071</ArticleId></ArticleIdList></Reference><Reference><Citation>Andr&#xe9;s-Rodr&#xed;guez L, Borr&#xe0;s X, Feliu-Soler A, P&#xe9;rez-Aranda A, Rozadilla-Sacanell A, Montero-Marin J et al. Immune-inflammatory pathways and clinical changes in fibromyalgia patients treated with Mindfulness-Based Stress Reduction (MBSR): A randomized, controlled clinical trial. Brain Behav Immun. 2019;80(December 2018):109&#x2013;19. 10.1016/j.bbi.2019.02.030</Citation><ArticleIdList><ArticleId IdType="pubmed">30818032</ArticleId></ArticleIdList></Reference><Reference><Citation>Cash E, Salmon P, Weissbecker I, Rebholz WN, Bayley-Veloso R, Zimmaro LA et al. Mindfulness meditation alleviates fibromyalgia symptoms in women: results of a randomized clinical trial. Ann Behav Med. 2015;49(3):319&#x2013;30. Available from: https://www.embase.com/search/results?subaction=viewrecord&amp;id=L607906153&amp;from=export.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4802162</ArticleId><ArticleId IdType="pubmed">25425224</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Aranda A, Feliu-Soler A, Montero-Marin J, Garcia-Campayo J, Andres-Rodriguez L, Borras X, et al. A randomized controlled efficacy trial of mindfulness-based stress reduction compared with an active control group and usual care for fibromyalgia: the EUDAIMON study. Pain. 2019;160(11):2508&#x2013;23. doi: 10.1097/j.pain.0000000000001655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000001655</ArticleId><ArticleId IdType="pubmed">31356450</ArticleId></ArticleIdList></Reference><Reference><Citation>Quirk GJ, Garcia R, Gonz&#xe1;lez-Lima F. Prefrontal mechanisms in extinction of conditioned fear. Biol Psychiatry. 2006;60(4):337&#x2013;43. doi: 10.1016/j.biopsych.2006.03.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2006.03.010</ArticleId><ArticleId IdType="pubmed">16712801</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A. Can amygdala retraining techniques improve the wellbeing of patients with Chronic Fatigue Syndrome. J Holist Healthc. 2010;7(2):12&#x2013;5.</Citation></Reference><Reference><Citation>Gupta A. Unconscious amygdalar fear conditioning in a subset of Chronic Fatigue Syndrome patients. Med Hypotheses. 2002;59(6):727&#x2013;35. doi: 10.1016/S0306-9877(02)00321-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0306-9877(02)00321-3</ArticleId><ArticleId IdType="pubmed">12445517</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint LL, Whipple MO, Abboud LL, Vincent A, Wahner-Roedler DL. A mind-body technique for symptoms related to fibromyalgia and chronic fatigue. Explor J Sci Heal. 2012;8(2):92&#x2013;8. 10.1016/j.explore.2011.12.003</Citation><ArticleIdList><ArticleId IdType="pubmed">22385563</ArticleId></ArticleIdList></Reference><Reference><Citation>Gotink RA, Meijboom R, Vernooij MW, Smits M, Hunink MGM. 8-week Mindfulness Based Stress Reduction induces brain changes similar to traditional long-term meditation practice &#x2013; A systematic review. Brain Cogn. 2016;108:32&#x2013;41. 10.1016/j.bandc.2016.07.001</Citation><ArticleIdList><ArticleId IdType="pubmed">27429096</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanabria-Mazo JP, Montero-Marin J, Feliu-Soler A, Gasi&#xf3;n V, Navarro-Gil M, Morillo-Sarto H et al. Mindfulness-based program plus amygdala and insula retraining (MAIR) for the treatment of women with fibromyalgia: A pilot randomized controlled trial. J Clin Med. 2020;9(10):1&#x2013;16. Available from: https://www.embase.com/search/results?subaction=viewrecord&amp;id=L2005203889&amp;from=export.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7599726</ArticleId><ArticleId IdType="pubmed">33050630</ArticleId></ArticleIdList></Reference><Reference><Citation>Mayorga NA, Manning KF, Garey L, Viana AG, Ditre JW, Zvolensky MJ. The Role of Experiential Avoidance in Terms of Fatigue and Pain During COVID-19 Among Latinx Adults. Cognit Ther Res. 2022;46(3):470&#x2013;9. 10.1007/s10608-022-10292-2</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8802248</ArticleId><ArticleId IdType="pubmed">35125558</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenning K, Waterschoot J, Dieleman L, Morb&#xe9;e S, Vermote B, Soenens B et al. The role of emotion regulation in mental health during the COVID-19 outbreak: a 10-wave longitudinal study. Stress Heal. 2022;(September).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9874444</ArticleId><ArticleId IdType="pubmed">36252954</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan RM, Deci EL. Self-determination theory: Basic Psychological needs in motivation, Development, and Wellness. Guilford Publications; 2017. p. 756.</Citation></Reference><Reference><Citation>Toussaint LL, Bratty AJ. Amygdala and Insula Retraining (AIR) Significantly Reduces Fatigue and Increases Energy in People with Long COVID. Zahiruddin S, editor. Evidence-Based Complement Altern Med. 2023;2023:1&#x2013;8. Available from: https://www.hindawi.com/journals/ecam/2023/7068326/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10365910</ArticleId><ArticleId IdType="pubmed">37492483</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban F, Leber A, Jawad MY, Yu M, Lui LMW, Subramaniapillai M et al. Registered clinical trials investigating treatment of long COVID: a scoping review and recommendations for research. Infect Dis (Auckl). 2022;54(7):467&#x2013;77. 10.1080/23744235.2022.2043560</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8935463</ArticleId><ArticleId IdType="pubmed">35282780</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawke LD, Nguyen ATP, Ski CF, Thompson DR, Ma C, Castle D. Interventions for mental health, cognition, and psychological wellbeing in long COVID: a systematic review of registered trials. Psychol Med. 2022;52(13):2426&#x2013;40. doi: 10.1017/S0033291722002203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291722002203</ArticleId><ArticleId IdType="pmc">PMC9300978</ArticleId><ArticleId IdType="pubmed">35768406</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Jabr H, Hawke LD, Thompson DR, Clifton A, Shenton M, Castle DJ et al. Interventions to support mental health in people with long COVID: a scoping review. BMC Public Health. 2023;23(1):1&#x2013;18. 10.1186/s12889-023-16079-8</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10280822</ArticleId><ArticleId IdType="pubmed">37340400</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan A, Tetzlaff JM, Altman DG. 2013 Statement: Defining Standard Protocol Items for Clinical Trials. Ann Intern Med. 2016;158(3):200&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5114123</ArticleId><ArticleId IdType="pubmed">23295957</ArticleId></ArticleIdList></Reference><Reference><Citation>Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8(18).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2860339</ArticleId><ArticleId IdType="pubmed">20334633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL. The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther. 2009;11(4):1&#x2013;14. doi: 10.1186/ar2783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2783</ArticleId><ArticleId IdType="pmc">PMC2745803</ArticleId><ArticleId IdType="pubmed">19664287</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero-Marin J, Navarro-Gil M, Puebla-Guedea M, Luciano JV, Van Gordon W, Shonin E et al. Efficacy of &#x2018;Attachment-Based Compassion Therapy&#x2019; in the treatment of Fibromyalgia: a Randomized Controlled Trial. Front PSYCHIATRY. 2018;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5775966</ArticleId><ArticleId IdType="pubmed">29387020</ArticleId></ArticleIdList></Reference><Reference><Citation>Baer R, Crane C, Montero-Marin J, Phillips A, Taylor L, Tickell A, et al. Frequency of self-reported unpleasant events and harm in a mindfulness-based program in two General Population samples. Mindfulness (N Y) 2021;12(3):763&#x2013;74. doi: 10.1007/s12671-020-01547-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12671-020-01547-8</ArticleId><ArticleId IdType="pmc">PMC7920887</ArticleId><ArticleId IdType="pubmed">33747251</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotres-Bayon F, Cain CK, LeDoux JE. Brain mechanisms of fear extinction: historical perspectives on the contribution of Prefrontal Cortex. Biol Psychiatry. 2006;60(4):329&#x2013;36. doi: 10.1016/j.biopsych.2005.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsych.2005.10.012</ArticleId><ArticleId IdType="pubmed">16412988</ArticleId></ArticleIdList></Reference><Reference><Citation>Johansen JP, Tarpley JW, LeDoux JE, Blair HT. Neural substrates for expectation-modulated fear learning in the amygdala and periaqueductal gray. Nat Neurosci. 2010;13(8):979&#x2013;86. Available from: https://www.nature.com/articles/nn.2594</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2910797</ArticleId><ArticleId IdType="pubmed">20601946</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldin PR, Gross JJ. Effects of mindfulness-based stress reduction (MBSR) on emotion regulation in social anxiety disorder. Emotion. 2010;10(1):83&#x2013;91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20141305</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4203918</ArticleId><ArticleId IdType="pubmed">20141305</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xf6;lzel BK, Carmody J, Evans KC, Hoge EA, Dusek JA, Morgan L, et al. Stress reduction correlates with structural changes in the amygdala. Soc Cogn Affect Neurosci. 2009;5(1):11&#x2013;7. doi: 10.1093/scan/nsp034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/scan/nsp034</ArticleId><ArticleId IdType="pmc">PMC2840837</ArticleId><ArticleId IdType="pubmed">19776221</ArticleId></ArticleIdList></Reference><Reference><Citation>Kral TRA, Schuyler BS, Mumford JA, Rosenkranz MA, Lutz A, Davidson RJ. Impact of short- and long-term mindfulness meditation training on amygdala reactivity to emotional stimuli. Neuroimage. 2018;181(1):301&#x2013;13. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1053811918306256</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671286</ArticleId><ArticleId IdType="pubmed">29990584</ArticleId></ArticleIdList></Reference><Reference><Citation>Porter N, Jason LA. Mindfulness Meditation interventions for Long COVID: Biobehavioral Gene expression and Neuroimmune Functioning. Neuropsychiatr Dis Treat. 2022;18(October):2599&#x2013;626. doi: 10.2147/NDT.S379653.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S379653</ArticleId><ArticleId IdType="pmc">PMC9653042</ArticleId><ArticleId IdType="pubmed">36387947</ArticleId></ArticleIdList></Reference><Reference><Citation>Natarajan A, Shetty A, Delanerolle G, Zeng Y, Zhang Y, Raymont V et al. A systematic review and meta-analysis of long COVID symptoms. Syst Rev. 2023;12(1):1&#x2013;19. 10.1186/s13643-023-02250-0</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10220332</ArticleId><ArticleId IdType="pubmed">37245047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernstein DA, Borkovec TD. Progressive relaxation training: a manual for the helping professions. Research Press.; 1973. p. 80.</Citation></Reference><Reference><Citation>Alonso J, Prieto L, Ant&#xf3; J. The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results. Med Clin. 1995;104:771&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">7783470</ArticleId></ArticleIdList></Reference><Reference><Citation>Alonso J, Prieto L, Ferrer M, Vilagut G, Broquetas JM, Roca J, et al. Testing the measurement properties of the Spanish version of the SF-36 Health Survey among male patients with Chronic Obstructive Pulmonary Disease. J Clin Epidemiol. 1998;51(11):1087&#x2013;94. doi: 10.1016/S0895-4356(98)00100-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0895-4356(98)00100-0</ArticleId><ArticleId IdType="pubmed">9817126</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilagut G, Ferrer M, Rajmil L, Rebollo P, Permanyer-Miralda G, Quintana JM et al. The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit. 2005;19(2):135&#x2013;50. 10.1157/13074369</Citation><ArticleIdList><ArticleId IdType="pubmed">15860162</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-L&#xf3;pez R, Pagerols M, Collado A. Cuestionario Del dolor en espa&#xf1;ol: resultados de Su Empleo Sistematizado Durante El Periodo 1990-93. Pain. 1993;11(6).</Citation></Reference><Reference><Citation>Ferrer-Pe&#xf1;a R, Gil-Mart&#xed;nez A, Pardo-Montero J, Jim&#xe9;nez-Penick V, Gallego-Izquierdo T, La Touche R. Adaptaci&#xf3;n y validaci&#xf3;n de la Escala de gradaci&#xf3;n del dolor cr&#xf3;nico al espa&#xf1;ol. Reumatol Clin. 2016;12(3):130&#x2013;8. Available from: https://linkinghub.elsevier.com/retrieve/pii/S1699258X15001205</Citation><ArticleIdList><ArticleId IdType="pubmed">26298083</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a Campayo J, Rodero B, Alda M, Sobradiel N, Montero J, Moreno S. Validaci&#xf3;n de la versi&#xf3;n espa&#xf1;ola de la escala de la catastrofizaci&#xf3;n ante el dolor (Pain Catastrophizing Scale) en la fibromialgia. Med Clin (Barc). 2008;131(13):487&#x2013;92. 10.1157/13127277</Citation><ArticleIdList><ArticleId IdType="pubmed">19007576</ArticleId></ArticleIdList></Reference><Reference><Citation>Kos D, Kerckhofs E, Carrea I, Verza R, Ramos M, Jansa J. Evaluation of the modified fatigue impact scale in four different European countries. Mult Scler. 2005;11(1):76&#x2013;80. doi: 10.1191/1352458505ms1117oa.</Citation><ArticleIdList><ArticleId IdType="doi">10.1191/1352458505ms1117oa</ArticleId><ArticleId IdType="pubmed">15732270</ArticleId></ArticleIdList></Reference><Reference><Citation>Morin CM, Belleville G, B&#xe9;langer L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34(5):601&#x2013;8. doi: 10.1093/sleep/34.5.601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sleep/34.5.601</ArticleId><ArticleId IdType="pmc">PMC3079939</ArticleId><ArticleId IdType="pubmed">21532953</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Mendoza J, Rodriguez-Mu&#xf1;oz A, Vela-Bueno A, Olavarrieta-Bernardino S, Calhoun SL, Bixler EO et al. The Spanish version of the Insomnia Severity Index: A confirmatory factor analysis. Sleep Med. 2012;13(2):207&#x2013;10. 10.1016/j.sleep.2011.06.019</Citation><ArticleIdList><ArticleId IdType="pubmed">22172961</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer R, Kroenke K, Williams J, L&#xf6;we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092&#x2013;7. doi: 10.1001/archinte.166.10.1092.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Campayo J, Zamorano E, Ru&#xed;z MA, Pardo A, Freire O, P&#xe9;rez-P&#xe1;ramo M, et al. Cultural Adaptation into Spanish of the generalized anxiety disorder Scale-7 (GAD-7) scale. Eur Psychiatry. 2009;24(S1):1&#x2013;1. doi: 10.1016/S0924-9338(09)70771-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0924-9338(09)70771-0</ArticleId><ArticleId IdType="pmc">PMC2831043</ArticleId><ArticleId IdType="pubmed">20089179</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606&#x2013;13. doi: 10.1046/j.1525-1497.2001.016009606.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.016009606.x</ArticleId><ArticleId IdType="pmc">PMC1495268</ArticleId><ArticleId IdType="pubmed">11556941</ArticleId></ArticleIdList></Reference><Reference><Citation>Diez-Quevedo C, Rangil T, Sanchez-Planell L, Kroenke K, Spitzer RL. Validation and Utility of the Patient Health Questionnaire in Diagnosing Mental Disorders in 1003 General Hospital Spanish Inpatients. Psychosom Med. 2001;686(63):679&#x2013;86. Available from: https://journals.lww.com/psychosomaticmedicine/Abstract/2001/07000/Validation_and_Utility_of_the_Patient_Health.21.aspxhttps://citeseerx.ist.psu.edu/viewdoc/download?doi=10.1.1.540.3655&amp;rep=rep1&amp;type=pdf</Citation><ArticleIdList><ArticleId IdType="pubmed">11485122</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozoya Delgado P, Ruiz S&#xe1;nchez de Le&#xf3;n JM, Pedrero P&#xe9;rez EJ. Validaci&#xf3;n De Un cuestionario de quejas cognitivas para adultos j&#xf3;venes: relaci&#xf3;n entre las quejas subjetivas de memoria, la sintomatolog&#xed;a prefrontal y El estr&#xe9;s percibido. Rev Neurol. 2012;54(03):137.</Citation><ArticleIdList><ArticleId IdType="pubmed">22278890</ArticleId></ArticleIdList></Reference><Reference><Citation>Bohlmeijer E, Klooster PM, Fledderus M, Veehof M, Baer R. Psychometric properties of the five facet mindfulness questionnaire in depressed adults and development of a short form. Assessment. 2011;18(3):308&#x2013;20. doi: 10.1177/1073191111408231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1073191111408231</ArticleId><ArticleId IdType="pubmed">21586480</ArticleId></ArticleIdList></Reference><Reference><Citation>Asensio-Mart&#xed;nez &#xc1;, Masluk B, Montero-Marin J, Olivan-Bl&#xe1;zquez B, Navarro-Gil MT, Garc&#xed;a-Campayo J, et al. Validation of five facets Mindfulness Questionnaire &#x2013; Short form, in Spanish, general health care services patients sample: prediction of depression through mindfulness scale. PLoS ONE. 2019;14(4):1&#x2013;17. doi: 10.1371/journal.pone.0214503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0214503</ArticleId><ArticleId IdType="pmc">PMC6445454</ArticleId><ArticleId IdType="pubmed">30939151</ArticleId></ArticleIdList></Reference><Reference><Citation>Gross JJ, John OP. Individual differences in two emotion regulation processes: implications for Affect, relationships, and well-being. J Pers Soc Psychol. 2003;85(2):348&#x2013;62. doi: 10.1037/0022-3514.85.2.348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0022-3514.85.2.348</ArticleId><ArticleId IdType="pubmed">12916575</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabello R, Salguero JM, Fern&#xe1;ndez-Berrocal P, Gross JJ. A Spanish adaptation of the emotion regulation questionnaire. Eur J Psychol Assess. 2013;29(4):234&#x2013;40. doi: 10.1027/1015-5759/a000150.</Citation><ArticleIdList><ArticleId IdType="doi">10.1027/1015-5759/a000150</ArticleId></ArticleIdList></Reference><Reference><Citation>Bond FW, Hayes SC, Baer RA, Carpenter KM, Guenole N, Orcutt HK, et al. Preliminary Psychometric properties of the Acceptance and Action Questionnaire-II: a revised measure of psychological inflexibility and experiential avoidance. Behav Ther. 2011;42(4):676&#x2013;88. doi: 10.1016/j.beth.2011.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beth.2011.03.007</ArticleId><ArticleId IdType="pubmed">22035996</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz FJ, Langer Herrera &#xc1;I, Luciano C, Cangas AJ, Beltr&#xe1;n I. Measuring experiential avoidance and psychological inflexibility: the Spanish version of the Acceptance and Action Questionnaire-II. Psicothema. 2013;25(1):123&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23336554</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson NS, Truax P. Clinical significance: A statistical approach to defining meaningful change in psychotherapy research. J Consult Clin Psychol. 1991;59(1):12&#x2013;9. Available from: http://doi.apa.org/getdoi.cfm?doi=10.1037/0022-006X.59.1.12.</Citation><ArticleIdList><ArticleId IdType="pubmed">2002127</ArticleId></ArticleIdList></Reference><Reference><Citation>Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Stat. 2001;29(4):1165&#x2013;88. Available from: https://projecteuclid.org/journals/annals-of-statistics/volume-29/issue-4/The-control-of-the-false-discovery-rate-in-multiple-testing/10.1214/aos/1013699998.full</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/aos/1013699998.full</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Toro A, Bozzani A, Tavazzi G, Urtis M, Giuliani L, Pizzoccheri R, et al. Long COVID: long-term effects? Eur Hear Journal Suppl. 2021;23:E1&#x2013;5. doi: 10.1093/eurheartj/suab080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/suab080</ArticleId><ArticleId IdType="pmc">PMC8503490</ArticleId><ArticleId IdType="pubmed">34650349</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronese N, Bonica R, Cotugno S, Tulone O, Camporeale M, Smith L, et al. Interventions for improving long COVID-19 symptomatology: a systematic review. Viruses. 2022;14(9):1&#x2013;9. doi: 10.3390/v14091863.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14091863</ArticleId><ArticleId IdType="pmc">PMC9502379</ArticleId><ArticleId IdType="pubmed">36146672</ArticleId></ArticleIdList></Reference><Reference><Citation>Schrimpf A, Braesigk A, Lippmann S, Bleckwenn M. Management and treatment of long COVID symptoms in general practices: an online-based survey. Front Public Heal. 2022;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513068</ArticleId><ArticleId IdType="pubmed">36176520</ArticleId></ArticleIdList></Reference><Reference><Citation>Montero-Marin J, Andr&#xe9;s-Rodr&#xed;guez L, Tops M, Luciano JV, Navarro-Gil M, Feliu-Soler A et al. Effects of attachment-based compassion therapy (ABCT) on brain-derived neurotrophic factor and low-grade inflammation among fibromyalgia patients: A randomized controlled trial. Sci Rep. 2019;9(1):15639. Available from: https://www.embase.com/search/results?subaction=viewrecord&amp;id=L629732772&amp;from=export.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6821772</ArticleId><ArticleId IdType="pubmed">31666651</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma SH, Teasdale JD. Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects. J Consult Clin Psychol. 2004;72(1):31&#x2013;40. Available from: http://www.embase.com/search/results?subaction=viewrecord&amp;from=export&amp;id=L38380527</Citation><ArticleIdList><ArticleId IdType="pubmed">14756612</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>